Monthly Archives: May 2014

The CONSORT Statement in 2014: from Miró to Pollock?

With the advent of the AllTrials initiative, the EU Clinical Trials Regulation and the recent Tamiflu debacle, randomized controlled trials (RCTs) have received a lot of attention over the last 12 months. Despite all this recent furore surrounding the reporting of RCTs, there are those of us who have been banging this drum for a… Read more »

2

Personalizing care in coronary heart disease

Heart

A new paper published in Genome Medicine today describes research with the potential to ‘personalize’ treatment for patients with heart disease.   Determining whether or not certain treatments or interventions are right for a particular patient is a tricky business. Much of the time it is about weighing up the benefits versus potential side effects… Read more »

Focal Segmental Glomerulosclerosis and the future of nephrology

Focal_segmental_glomerulosclerosis

A new article about Focal Segmental Glomerulosclerosis (FSGS) – a progressive kidney disease – was published in BMC Medicine today. We spoke to Jochen Reiser, an expert in the field, and Chairman of Medicine at Rush University, Chicago, to find out more about FSGS and what these latest results add to our understanding. What exactly… Read more »

Exploring the health benefits of the Mediterranean diet: polyphenols, olive oil and longevity

Mediterranean diet (cropped)

Many different food types – from the school dinner favorite broccoli to traditional Chinese goji berries – have been termed ‘superfoods’ in recent years, due to their reported beneficial effects on longevity and disease prevention. The health gains of these foods are largely attributed to their antioxidant content, but evidence behind the benefits of consuming… Read more »